TY - JOUR
T1 - Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection
AU - Heaton, Nicholas S.
AU - Moshkina, Natasha
AU - Fenouil, Romain
AU - Gardner, Thomas J.
AU - Aguirre, Sebastian
AU - Shah, Priya S.
AU - Zhao, Nan
AU - Manganaro, Lara
AU - Hultquist, Judd F.
AU - Noel, Justine
AU - Sachs, David H.
AU - Hamilton, Jennifer
AU - Leon, Paul E.
AU - Chawdury, Amit
AU - Tripathi, Shashank
AU - Melegari, Camilla
AU - Campisi, Laura
AU - Hai, Rong
AU - Metreveli, Giorgi
AU - Gamarnik, Andrea V.
AU - García-Sastre, Adolfo
AU - Greenbaum, Benjamin
AU - Simon, Viviana
AU - Fernandez-Sesma, Ana
AU - Krogan, Nevan J.
AU - Mulder, Lubbertus C.F.
AU - van Bakel, Harm
AU - Tortorella, Domenico
AU - Taunton, Jack
AU - Palese, Peter
AU - Marazzi, Ivan
N1 - Funding Information:
We would like to thank Ryan Langlois, Megan Shaw, and Andres Finzi for their expertise and helpful discussions; Daria Brinzevich and Raymond Alvarez for their technical assistance; and Hector Delgado for his artwork in the graphical abstract. We would also like to thank the flow-cytometry shared resource facilitiy and the high-performance scientific computing facility at the Icahn School of Medicine at Mount Sinai and the proteomics facility at Rockefeller University. N.S.H. is a Merck fellow of the Life Sciences Research Foundation. V.S. is partially supported by the NIH-NIAID grants R01 AI089246 and P01 AI090935. D.T. is partially supported by NIH grant AI101820. P.P., A.G., G.M., H.v.B., and I.M. are partially supported by HHSN272201400008C from the Center for Research on Influenza Pathogenesis (CRIP), a NIAID-funded Center of Excellence for Influenza Research and Surveillance (CEIRS). L.C.F.M is supported by NIH-NIGMS grant R01 GM113886. N.M. is supported in part by a Public Health Service Institutional Research Training Award (AI07647). I.M. is supported in part by The Department of Defense W911NF-14-1-0353 (to I.M.) and by NIH grants U19AI106754 (to I.M. and A.G-S.), 1R01AN3663134 (to I.M and H.v.B.), and 1R56AI114770-01A1 (to I.M.)
Funding Information:
We would like to thank Ryan Langlois, Megan Shaw, and Andres Finzi for their expertise and helpful discussions; Daria Brinzevich and Raymond Alvarez for their technical assistance; and Hector Delgado for his artwork in the graphical abstract. We would also like to thank the flow-cytometry shared resource facilitiy and the high-performance scientific computing facility at the Icahn School of Medicine at Mount Sinai and the proteomics facility at Rockefeller University. N.S.H. is a Merck fellow of the Life Sciences Research Foundation . V.S. is partially supported by the NIH-NIAID grants R01 AI089246 and P01 AI090935 . D.T. is partially supported by NIH grant AI101820 . P.P., A.G., G.M., H.v.B., and I.M. are partially supported by HHSN272201400008C from the Center for Research on Influenza Pathogenesis (CRIP), a NIAID -funded Center of Excellence for Influenza Research and Surveillance (CEIRS). L.C.F.M is supported by NIH-NIGMS grant R01 GM113886 . N.M. is supported in part by a Public Health Service Institutional Research Training Award ( AI07647 ). I.M. is supported in part by The Department of Defense W911NF-14-1-0353 (to I.M.) and by NIH grants U19AI106754 (to I.M. and A.G-S.), 1R01AN3663134 (to I.M and H.v.B.), and 1R56AI114770-01A1 (to I.M.)
Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/1/19
Y1 - 2016/1/19
N2 - Viruses are obligate parasites and thus require the machinery of the host cell to replicate. Inhibition of host factors co-opted during active infection is a strategy hosts use to suppress viral replication and a potential pan-antiviral therapy. To define the cellular proteins and processes required for a virus during infection is thus crucial to understanding the mechanisms of virally induced disease. In this report, we generated fully infectious tagged influenza viruses and used infection-based proteomics to identify pivotal arms of cellular signaling required for influenza virus growth and infectivity. Using mathematical modeling and genetic and pharmacologic approaches, we revealed that modulation of Sec61-mediated cotranslational translocation selectively impaired glycoprotein proteostasis of influenza as well as HIV and dengue viruses and led to inhibition of viral growth and infectivity. Thus, by studying virus-human protein-protein interactions in the context of active replication, we have identified targetable host factors for broad-spectrum antiviral therapies. Viruses are obligate parasites dependent on the host cell machinery. Using infection-based proteomics, biochemistry, and mathematical modeling, Marazzi and colleagues reveal that targeting host factors controlling essential cellular functions can provide broad-spectrum antiviral effects. Loss-of-function and chemical inhibition of one such factor, Sec61, inhibited influenza, HIV, and dengue virus replication.
AB - Viruses are obligate parasites and thus require the machinery of the host cell to replicate. Inhibition of host factors co-opted during active infection is a strategy hosts use to suppress viral replication and a potential pan-antiviral therapy. To define the cellular proteins and processes required for a virus during infection is thus crucial to understanding the mechanisms of virally induced disease. In this report, we generated fully infectious tagged influenza viruses and used infection-based proteomics to identify pivotal arms of cellular signaling required for influenza virus growth and infectivity. Using mathematical modeling and genetic and pharmacologic approaches, we revealed that modulation of Sec61-mediated cotranslational translocation selectively impaired glycoprotein proteostasis of influenza as well as HIV and dengue viruses and led to inhibition of viral growth and infectivity. Thus, by studying virus-human protein-protein interactions in the context of active replication, we have identified targetable host factors for broad-spectrum antiviral therapies. Viruses are obligate parasites dependent on the host cell machinery. Using infection-based proteomics, biochemistry, and mathematical modeling, Marazzi and colleagues reveal that targeting host factors controlling essential cellular functions can provide broad-spectrum antiviral effects. Loss-of-function and chemical inhibition of one such factor, Sec61, inhibited influenza, HIV, and dengue virus replication.
UR - http://www.scopus.com/inward/record.url?scp=84959065735&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959065735&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2015.12.017
DO - 10.1016/j.immuni.2015.12.017
M3 - Article
C2 - 26789921
AN - SCOPUS:84959065735
SN - 1074-7613
VL - 44
SP - 46
EP - 58
JO - Immunity
JF - Immunity
IS - 1
ER -